Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Suv39h2 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Suv39h2 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of SUV39H2 mRNA | CTD | PMID:22206623 | Suv39h2 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Suv39h2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SUV39H2 mRNA | CTD | PMID:17942748 | Suv39h2 | Rat | 17beta-estradiol | increases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Estradiol results in increased expression of SUV39H2 mRNA | CTD | PMID:19167446|PMID:31614463 | Suv39h2 | Rat | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Suv39h2 (Mus musculus) | 6480464 | 2,3',4,4',5-pentachlorobiphenyl results in increased expression of SUV39H2 mRNA | CTD | PMID:31388691 | Suv39h2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Suv39h2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SUV39H2 mRNA | CTD | PMID:17942748 | Suv39h2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SUV39H2 mRNA | CTD | PMID:32109520 | Suv39h2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Suv39h2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SUV39H2 mRNA | CTD | PMID:21570461 | Suv39h2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SUV39H2 mRNA | CTD | PMID:22298810 | Suv39h2 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of SUV39H2 mRNA | CTD | PMID:30851411 | Suv39h2 | Rat | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Suv39h2 (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SUV39H2 mRNA | CTD | PMID:20188158 | Suv39h2 | Rat | aflatoxin B1 | increases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of SUV39H2 mRNA | CTD | PMID:22100608 | Suv39h2 | Rat | aflatoxin B1 | decreases methylation | ISO | SUV39H2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SUV39H2 gene | CTD | PMID:27153756 | Suv39h2 | Rat | all-trans-retinoic acid | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of SUV39H2 mRNA | CTD | PMID:33167477 | Suv39h2 | Rat | benzo[a]pyrene | increases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of SUV39H2 mRNA | CTD | PMID:32234424 | Suv39h2 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SUV39H2 mRNA | CTD | PMID:20382639 | Suv39h2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SUV39H2 mRNA | CTD | PMID:25181051 | Suv39h2 | Rat | cadmium atom | multiple interactions | ISO | Suv39h2 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SUV39H2 more ... | CTD | PMID:37236586 | Suv39h2 | Rat | cadmium dichloride | multiple interactions | ISO | Suv39h2 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SUV39H2 more ... | CTD | PMID:37236586 | Suv39h2 | Rat | calcitriol | multiple interactions | ISO | SUV39H2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of SUV39H2 mRNA | CTD | PMID:21592394 | Suv39h2 | Rat | calcitriol | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of SUV39H2 mRNA | CTD | PMID:21592394 | Suv39h2 | Rat | carbon nanotube | decreases expression | ISO | Suv39h2 (Mus musculus) | 6480464 | Nanotubes, Carbon results in decreased expression of SUV39H2 mRNA | CTD | PMID:25554681 | Suv39h2 | Rat | chlorpyrifos | decreases expression | ISO | Suv39h2 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of SUV39H2 mRNA | CTD | PMID:37019170 | Suv39h2 | Rat | choline | multiple interactions | ISO | Suv39h2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Suv39h2 | Rat | cisplatin | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of SUV39H2 mRNA | CTD | PMID:27392435 | Suv39h2 | Rat | copper atom | multiple interactions | ISO | SUV39H2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SUV39H2 mRNA | CTD | PMID:20971185 | Suv39h2 | Rat | copper(0) | multiple interactions | ISO | SUV39H2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SUV39H2 mRNA | CTD | PMID:20971185 | Suv39h2 | Rat | copper(II) sulfate | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of SUV39H2 mRNA | CTD | PMID:19549813 | Suv39h2 | Rat | coumarin | decreases phosphorylation | ISO | SUV39H2 (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of SUV39H2 protein | CTD | PMID:35688186 | Suv39h2 | Rat | coumestrol | increases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of SUV39H2 mRNA | CTD | PMID:19167446 | Suv39h2 | Rat | coumestrol | multiple interactions | ISO | SUV39H2 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SUV39H2 mRNA; [Coumestrol co-treated with resveratrol] more ... | CTD | PMID:19167446 | Suv39h2 | Rat | cylindrospermopsin | increases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | cylindrospermopsin results in increased expression of SUV39H2 mRNA | CTD | PMID:24921660 | Suv39h2 | Rat | decabromodiphenyl ether | multiple interactions | EXP | | 6480464 | [Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in more ... | CTD | PMID:32207525 | Suv39h2 | Rat | dexamethasone | multiple interactions | ISO | SUV39H2 (Homo sapiens) | 6480464 | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of SUV39H2 more ... | CTD | PMID:26424790 | Suv39h2 | Rat | dicrotophos | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of SUV39H2 mRNA | CTD | PMID:28302478 | Suv39h2 | Rat | dorsomorphin | multiple interactions | ISO | SUV39H2 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Suv39h2 | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of SUV39H2 mRNA | CTD | PMID:29391264 | Suv39h2 | Rat | Enterolactone | multiple interactions | ISO | SUV39H2 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SUV39H2 mRNA | CTD | PMID:19167446 | Suv39h2 | Rat | epoxiconazole | decreases expression | ISO | Suv39h2 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of SUV39H2 mRNA | CTD | PMID:35436446 | Suv39h2 | Rat | ethanol | affects expression | ISO | Suv39h2 (Mus musculus) | 6480464 | Ethanol affects the expression of SUV39H2 mRNA | CTD | PMID:26730594 | Suv39h2 | Rat | ethanol | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Ethanol results in decreased expression of SUV39H2 mRNA | CTD | PMID:35149083 | Suv39h2 | Rat | ethyl methanesulfonate | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of SUV39H2 mRNA | CTD | PMID:23649840 | Suv39h2 | Rat | folic acid | multiple interactions | ISO | Suv39h2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Suv39h2 | Rat | folic acid | increases expression | ISO | Suv39h2 (Mus musculus) | 6480464 | Folic Acid results in increased expression of SUV39H2 mRNA | CTD | PMID:25629700 | Suv39h2 | Rat | FR900359 | decreases phosphorylation | ISO | SUV39H2 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of SUV39H2 protein | CTD | PMID:37730182 | Suv39h2 | Rat | glycerol 2-phosphate | multiple interactions | ISO | SUV39H2 (Homo sapiens) | 6480464 | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of SUV39H2 more ... | CTD | PMID:26424790 | Suv39h2 | Rat | GSK-J4 | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | GSK-J4 results in decreased expression of SUV39H2 mRNA | CTD | PMID:29301935 | Suv39h2 | Rat | hydrogen peroxide | affects expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of SUV39H2 mRNA | CTD | PMID:20044591 | Suv39h2 | Rat | L-ascorbic acid | multiple interactions | ISO | SUV39H2 (Homo sapiens) | 6480464 | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of SUV39H2 more ... | CTD | PMID:26424790 | Suv39h2 | Rat | L-methionine | multiple interactions | ISO | Suv39h2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Suv39h2 | Rat | lead(0) | affects expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Lead affects the expression of SUV39H2 mRNA | CTD | PMID:28903495 | Suv39h2 | Rat | methylmercury chloride | increases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of SUV39H2 mRNA | CTD | PMID:23179753 | Suv39h2 | Rat | nickel atom | increases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Nickel results in increased expression of SUV39H2 mRNA | CTD | PMID:25583101 | Suv39h2 | Rat | nitric oxide | increases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Nitric Oxide results in increased expression of SUV39H2 mRNA | CTD | PMID:23546878 | Suv39h2 | Rat | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of SUV39H2 mRNA | CTD | PMID:25729387 | Suv39h2 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of SUV39H2 mRNA | CTD | PMID:25729387 | Suv39h2 | Rat | ozone | multiple interactions | ISO | Suv39h2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased more ... | CTD | PMID:34911549 | Suv39h2 | Rat | p-chloromercuribenzoic acid | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of SUV39H2 mRNA | CTD | PMID:26272509 | Suv39h2 | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | SUV39H2 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Suv39h2 | Rat | paracetamol | decreases expression | ISO | Suv39h2 (Mus musculus) | 6480464 | Acetaminophen results in decreased expression of SUV39H2 mRNA | CTD | PMID:17585979 | Suv39h2 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SUV39H2 mRNA | CTD | PMID:33387578 | Suv39h2 | Rat | perfluorooctanoic acid | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of SUV39H2 mRNA | CTD | PMID:36326898 | Suv39h2 | Rat | phenylmercury acetate | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of SUV39H2 mRNA | CTD | PMID:26272509 | Suv39h2 | Rat | phenylmercury acetate | multiple interactions | ISO | SUV39H2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Suv39h2 | Rat | pirinixic acid | increases expression | ISO | Suv39h2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of SUV39H2 mRNA | CTD | PMID:20813756 | Suv39h2 | Rat | rac-lactic acid | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of SUV39H2 mRNA | CTD | PMID:30851411 | Suv39h2 | Rat | resveratrol | multiple interactions | ISO | SUV39H2 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of SUV39H2 mRNA | CTD | PMID:19167446 | Suv39h2 | Rat | SB 431542 | multiple interactions | ISO | SUV39H2 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Suv39h2 | Rat | sodium arsenite | decreases expression | ISO | Suv39h2 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of SUV39H2 mRNA | CTD | PMID:28414027 | Suv39h2 | Rat | sodium arsenite | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of SUV39H2 mRNA | CTD | PMID:38568856 | Suv39h2 | Rat | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of SUV39H2 mRNA | CTD | PMID:30557709|PMID:38578163 | Suv39h2 | Rat | sodium dichromate | affects expression | EXP | | 6480464 | sodium bichromate affects the expression of SUV39H2 mRNA | CTD | PMID:22110744 | Suv39h2 | Rat | succimer | multiple interactions | ISO | Suv39h2 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SUV39H2 mRNA; [Succimer co-treated more ... | CTD | PMID:21641980|PMID:26378955 | Suv39h2 | Rat | sunitinib | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of SUV39H2 mRNA | CTD | PMID:31533062 | Suv39h2 | Rat | testosterone | multiple interactions | ISO | SUV39H2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of SUV39H2 mRNA | CTD | PMID:21592394 | Suv39h2 | Rat | testosterone | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of SUV39H2 mRNA | CTD | PMID:21592394 | Suv39h2 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of SUV39H2 mRNA | CTD | PMID:23411599|PMID:34492290 | Suv39h2 | Rat | thiram | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Thiram results in decreased expression of SUV39H2 mRNA | CTD | PMID:38568856 | Suv39h2 | Rat | titanium dioxide | decreases methylation | ISO | Suv39h2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of SUV39H2 gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | Suv39h2 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of SUV39H2 mRNA | CTD | PMID:25729387 | Suv39h2 | Rat | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of SUV39H2 mRNA | CTD | PMID:33387578 | Suv39h2 | Rat | trimellitic anhydride | increases expression | ISO | Suv39h2 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of SUV39H2 mRNA | CTD | PMID:19042947 | Suv39h2 | Rat | triphenyl phosphate | affects expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of SUV39H2 mRNA | CTD | PMID:37042841 | Suv39h2 | Rat | valproic acid | decreases expression | ISO | Suv39h2 (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of SUV39H2 mRNA | CTD | PMID:21427059 | Suv39h2 | Rat | valproic acid | decreases methylation | ISO | SUV39H2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of SUV39H2 gene | CTD | PMID:29154799 | Suv39h2 | Rat | valproic acid | decreases expression | ISO | SUV39H2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SUV39H2 mRNA | CTD | PMID:28001369 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















